sh-Oligopeptide-9 for Hair Regrowth - Quick Reference Sheet

sh-Oligopeptide-9 for Hair Regrowth

Created on 09/27/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / GPT 6 – Audit

sh-Oligopeptide-9 is a laboratory-produced cosmetic ingredient proposed for hair regrowth. Applying it has not been shown to improve hair density, thickness, shedding, or visible coverage in people. Scalp comfort and skin-conditioning benefits remain untested; safety and the direction of any growth effect are uncertain. No established effective dose or continued-use schedule exists. Exact ingredient identity, product composition, and documented outcomes dominate practical assessment. (Full Review)

Protocol

Established regimen
No validated therapeutic protocol
No effective concentration, volume per scalp area, or treatment duration identified.
Topical formulations
Directions describe the whole formulation
They cannot establish an effective peptide dose or equivalent exposure.
Alternative approaches
No optimal approach identified
Topical use, needling, and injections are different exposures; other peptide protocols do not transfer.

Benefits

Contraindications
  • Known product allergy
  • Pregnancy or lactation (elective hair-regrowth use)
  • Children
  • Active scalp infection or open wounds (application at the affected site, especially invasive use)
Key Interactions
  • Prescription receptor blockers (naltrexone, naloxone) (theoretical caution)
  • Topical medications (minoxidil, tretinoin, ketoconazole)
  • Nonprescription products (exfoliating acids, alcohol-rich scalp products)
  • Supplements (biotin, iron, zinc, collagen, saw palmetto; interactions unknown)
  • Procedures (microneedling, injections, application immediately after transplantation)

Risk & Side Effects

  • High:
  • Medium:
  • Low:
  • Speculative: Scalp irritation or allergy; Unfavorable effects on hair growth; Infection or tissue injury with invasive delivery; Unintended effects beyond the scalp

Monitoring

Marker Target Why
Hair density in a fixed scalp area No established target; track hairs/cm² against individual baseline Quantify change
Hair-shaft diameter No established target; track change from individual baseline Assess thickness
Ferritin, when deficiency is suspected No established peptide-specific functional target; track deficiency and its correction Identify alternative cause
Thyroid-stimulating hormone, when indicated No established peptide-response target; track an identified thyroid disorder Identify alternative cause

Cadence: Baseline documentation; symptoms at weeks one and four; matched photographs and hair measurements at three and six months. Proposed documentation intervals, not a treatment schedule. No routine serial thyroid testing solely for peptide use.

Qualitative Assessment

  • Appearance: Satisfaction with coverage.
  • Tolerability: Dated itching, burning, tenderness, redness, scaling, or swelling.
  • Shedding: Sustained changes, considering illness, stress, and other treatments.